Quipt Home Medical Corp. (QIPT)

Quipt Home Medical Stock Forecast

Stock Price Forecast

The 2 analysts that cover Quipt Home Medical stock have a consensus rating of "Buy" and an average price target of $2.85, which forecasts a 58.33% increase in the stock price over the next year. The lowest target is $1.7 and the highest is $4.

Price Target: $2.85 (+58.33%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.70	$2.85	$4.00	$4.00
Change	-5.56%	+58.33%	+122.22%	+122.22%

* Price targets were last updated on May 14, 2025.

Analyst Ratings

The average analyst rating for Quipt Home Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	2	2	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Bill Sutherland Benchmark	Benchmark	Strong Buy Maintains $6 → $4	Strong Buy	Maintains	$6 → $4	+122.22%	May 14, 2025
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy → Hold Downgrades $4 → $1.7	Strong Buy → Hold	Downgrades	$4 → $1.7	-5.56%	May 13, 2025
Bill Sutherland Benchmark	Benchmark	Strong Buy Maintains $9 → $7	Strong Buy	Maintains	$9 → $7	+288.89%	Aug 21, 2024
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $8 → $6	Strong Buy	Maintains	$8 → $6	+233.33%	Aug 16, 2024
Bill Sutherland Benchmark	Benchmark	Strong Buy Maintains $10 → $9	Strong Buy	Maintains	$10 → $9	+400.00%	May 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

254.15M

Increased by 3.35%

from 245.92M

Revenue Next Year

267.84M

Increased by 5.39%

from 254.15M

EPS This Year

-0.08

from -0.16

EPS Next Year

-0.06

from -0.08

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Sep 30, 2020	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026	Sep 30, 2027
Revenue	72.64M	94.39M	127.64M	211.68M	245.92M	254.15M	267.84M	276.90M
Revenue Growth	18.77%	29.95%	35.22%	65.84%	16.18%	3.35%	5.39%	3.38%
EPS	-0.20	-0.20	0.13	-0.07	-0.16	-0.08	-0.06	-0.05
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	262.5M	281.6M	299.8M
Avg	254.2M	267.8M	276.9M
Low	242.4M	247.3M	252.3M

Revenue Growth

Revenue Growth	2025	2026	2027
High	6.7%	10.8%	11.9%
Avg	3.3%	5.4%	3.4%
Low	-1.4%	-2.7%	-5.8%

EPS Forecast

EPS	2025	2026	2027
High	0.05	0.01	0.02
Avg	-0.08	-0.06	-0.05
Low	-0.17	-0.15	-0.12

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.